Add Yahoo as a preferred source to see more of our stories on Google. Close-up of collection kit for personal genomics technology company 23AndMe on a retail store shelf, March 18, 2019. (Courtesy of ...

Add Yahoo as a preferred source to see more of our stories on Google. A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, ...

Editor’s Note: An earlier version of this piece failed to specify that the 23andMe sale is ongoing and is still subject to court approval. We have corrected this ...

23andMe, a distressed genetic testing company that filed for bankruptcy this year, has received another potential lifeline. A bankruptcy judge approved the sale of the company’s assets and business ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday. 23andMe filed for Chapter 11 bankruptcy protection in March. Last month, ...

Hackers used a credential stuffing attack to gain access to 23andMe accounts in October 2023. Ever used 23andMe? If you have, you might be able to get paid as part of the company's ongoing ...

A biotech future built on data: Regeneron’s acquisition of 23andMe blurs the line between pharmaceutical innovation and genetic surveillance. Unsplash+ “We are ...

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...

A bankruptcy judge approved the sale of genetics company 23andMe to a non-profit led by co-founder and former CEO Anne Wojcicki, according to a June 27 filing in the bankruptcy docket. TTAM Research ...

Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron ...